ICON PLC grants RSUs and options to CEO Balfe
ICON PLC Chief Executive Officer Barry Edward Balfe reported multiple equity transactions.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
ICON PLC Chief Executive Officer Barry Edward Balfe reported multiple equity transactions. On 2026-08-10 he received a grant of 22,258 Restricted Share Units, each convertible into one ordinary share, scheduled to vest in three approximately equal installments on March 8 of 2027, 2028, and 2029. He also received 32,635 stock options for ordinary shares at an exercise price of $166.05 per share, vesting in four approximately equal installments on March 8 of 2027, 2028, 2029, and 2030, and expiring on 2034-08-10, subject to limited automatic extension. On 2026-08-07, 728 Restricted Share Units from an August 7, 2023 grant vested and were converted into 728 ordinary shares. On 2026-08-10 he sold a total of 382 ordinary shares at prices of $163.80 and $165.14 per share to cover tax withholding obligations in connection with RSU vesting, which the company notes did not represent a discretionary transaction.
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
6 txns
Insider
Balfe Barry Edward
Role
Chief Executive Officer
Sold
382 shs ($63K)
Approx. gross sale proceeds
$63K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Share Units F1, F4 | 22,258 | $0.00 | $0.00 |
| Grant/Award | Stock Options F5, F6 | 32,635 | $0.00 | $0.00 |
| Sale | Ordinary Shares F3 | 304 | $163.80 | $50K |
| Sale | Ordinary Shares F3 | 78 | $165.14 | $13K |
| Exercise | Restricted Share Units F1, F2 | 728 | $0.00 | $0.00 |
| Exercise | Ordinary Shares F1, F2 | 728 | -- | -- |
Holdings After Transaction:
Restricted Share Units — 22,258 contracts (Direct);
Stock Options — 32,635 contracts (Direct);
Ordinary Shares — 4,804 shares (Direct)
Footnotes (6)
- F1. Each restricted share unit represents a contingent right to receive one ordinary share of the Issuer upon vesting, with a nominal conversion price equal to the par value of the ordinary shares (EUR 0.06) per underlying share automatically deducted from the reporting person's pay in connection with vesting.
- F2. These restricted share units were granted on August 7, 2023 and 728 restricted share units vested on August 7, 2026.
- F3. The sale reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- F4. These restricted share units were granted on August 10, 2026 and are scheduled to vest in three approximately equal installments on March 8, 2027, March 8, 2028, and March 8, 2029.
- F5. These stock options were granted on August 10, 2026 and are scheduled to vest in four approximately equal installments on March 8, 2027, March 8, 2028, March 8, 2029, and March 8, 2030.
- F6. The stock options expire on the eighth anniversary of the grant date, subject to automatic extension until the 30th trading day following any period during which trading is prohibited under the Issuer's Share Trading Policy or applicable law, but in no event later than the tenth anniversary of the grant date.
Key Figures
RSUs granted: 22,258 units
Stock options granted: 32,635 options
Option exercise price: $166.05 per share
+4 more
7 metrics
RSUs granted
22,258 units
Restricted Share Units granted to CEO on 2026-08-10, vesting in three installments
Stock options granted
32,635 options
Options for ordinary shares granted on 2026-08-10, vesting in four installments
Option exercise price
$166.05 per share
Exercise price for 32,635 stock options granted on 2026-08-10
Option expiration
2034-08-10
Stated expiration date for the 32,635 stock options, subject to limited extension
RSUs vested and converted
728 shares
728 RSUs from 2023 grant vested on 2026-08-07 and converted into ordinary shares
Shares sold to cover tax
382 shares
Ordinary shares sold on 2026-08-10 to cover tax withholding from RSU vesting
Sale prices
$163.80 and $165.14 per share
Per-share prices for 304 and 78 ordinary shares sold on 2026-08-10
Key Terms
Restricted Share Units, sell to cover, foreign private issuer, Rule 3a12-3(b), +1 more
5 terms
sell to cover financial
"The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction"
Sell to cover is when a person who receives company stock through options or awards sells just enough shares immediately to pay required taxes, exercise costs, or fees, keeping the rest. Think of it like cashing part of a bonus to cover the tax bill so you can keep the remainder. For investors, it can create predictable small selling pressure and slightly change the number of shares actually held by insiders without increasing long‑term dilution.
foreign private issuer regulatory
"Due to the issuer's status as a foreign private issuer pursuant to Rule 3a12-3(b)"
A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.
Rule 3a12-3(b) regulatory
"status as a foreign private issuer pursuant to Rule 3a12-3(b) under the Securities Exchange Act"
Sections 16(b) and 16(c) regulatory
"equity securities are exempt from Sections 16(b) and 16(c) of the Act"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did ICON PLC (ICLR) grant to CEO Barry Balfe on August 10, 2026?
On 2026-08-10, CEO Barry Balfe received 22,258 Restricted Share Units and 32,635 stock options for ICON PLC ordinary shares. The options have a $166.05 exercise price and vest in four approximately equal installments from March 8, 2027 through March 8, 2030.
How do Barry Balfe’s new ICON PLC (ICLR) RSUs vest over time?
The 22,258 Restricted Share Units granted on 2026-08-10 are scheduled to vest in three approximately equal installments. Vesting dates are March 8, 2027, March 8, 2028, and March 8, 2029, with each vested unit delivering one ordinary share subject to a nominal par value deduction.
What are the terms of Barry Balfe’s new ICON PLC (ICLR) stock options?
Barry Balfe’s new 32,635 stock options have a $166.05 exercise price and are scheduled to vest in four approximately equal installments on March 8, 2027, 2028, 2029, and 2030. The options expire on 2034-08-10, subject to limited automatic extension under trading restrictions.
What RSU vesting event did ICON PLC (ICLR) report for Barry Balfe on August 7, 2026?
On 2026-08-07, 728 Restricted Share Units from a grant dated August 7, 2023 vested for Barry Balfe. These vested RSUs converted into 728 ordinary shares, with a nominal conversion price equal to the par value per share deducted from his pay upon vesting.
Are Barry Balfe’s ICON PLC (ICLR) transactions subject to Section 16(b) rules?
The company states that, as a foreign private issuer under Rule 3a12-3(b), ICON PLC’s equity securities are exempt from Sections 16(b) and 16(c) of the Exchange Act. Therefore, Barry Balfe’s reported transactions are not subject to those short-swing profit rules.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates